By the end of the 12-week ATP , 24 ( 89 % ) patients were considered to be responders among the CP patients and 24 ( 89 % ) among the MMF patients ; 59 % and 37 % of patients in the CP group and 67 % and 48 % in the MMF group achieved an improvement of at least 75 % in subjective and objective scores , respectively .